Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

19 Nov 2019 | 04:01 PM

1,630.10
3.15 (0.19%)

  • Outperforms Index

    20.79%

    Return (1Y)

    Beaten S&P BSE Healthcare by 29.78%

  • More Volatile

    1.21%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.29%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,700

1,699.95

1,131

1,131.05

News & Announcements

Price vs Volume

Stock Trivia

  • Glaxosmithkline Pharma Ltd is trading very close to its 52 Week High

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -59.79% since past 3 Months

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 15.13% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -63.13% since past 1 Year

Loading...